CardioMEMS-Guided CAR T Cell Therapy for Lymphoma in a Patient With Anthracycline-Induced Cardiomyopathy

Anthony J Kanelidis; Jayant Raikhelkar; Gene Kim; Gabriel Sayer; Michael R Bishop; Tamar S Polonsky; Nir Uriel

doi:10.1016/j.jaccao.2020.06.005

CardioMEMS-Guided CAR T Cell Therapy for Lymphoma in a Patient With Anthracycline-Induced Cardiomyopathy

JACC CardioOncol. 2020 Sep 15;2(3):515-518. doi: 10.1016/j.jaccao.2020.06.005. eCollection 2020 Sep.

Authors

Anthony J Kanelidis¹, Jayant Raikhelkar², Gene Kim¹, Gabriel Sayer², Michael R Bishop³, Tamar S Polonsky¹, Nir Uriel²

Affiliations

¹ Section of Cardiology, University of Chicago Medical Center, Chicago, Illinois, USA.
² Section of Cardiology, Columbia University Medical Center, New York, New York, USA.
³ Section of Hematology/Oncology, University of Chicago Medical Center, Chicago, Illinois, USA.

No abstract available

Keywords: CAR, chimeric antigen receptor; CRS, cytokine release syndrome; DLBCL, diffuse large B-cell lymphoma; GDMT, guideline-directed medical therapy; HF, heart failure; LVEF, left ventricular ejection fraction; PAd, pulmonary artery diastolic pressure; R-CHOP, rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone; RHC, right heart catherization; TTE, transthoracic echocardiogram; anthracycline; cardiomyopathy; heart failure; immunotherapy; lymphoma.

Publication types

Review